Seurat Therapeutics
Chicago, US · Founded 2016 · Delaware corporation
Seurat Therapeutics is a biopharmaceutical company focused on discovering and developing novel neurotherapeutics, with research centered on immune signaling in brain health. Its work addresses conditions such as migraine and other neurological diseases.
Founders & leadership
YZ
Yuan ZhangNamed on SEC filing
MS
Martin SandersCo-Founder and Executive Chairman
SL
Sharon LewNamed on SEC filing
RK
Richard KraigCo-Founder, Chief Scientific Officer
Reported raises · per SEC filings
Form D private placements$773.5K disclosed across 1 round · 2018
▶$773.5KraisedFeb 2018 · 5 investors · BiotechnologyRule 506(b)
▶$773.5KraisedFeb 2018 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Yuan ZhangExecutive Officer, Director
- Martin SandersExecutive Officer, Director
- Sharon LewExecutive Officer
- Richard KraigExecutive Officer, Director
- Offering amount
- $773.5K
- Amount sold
- $773.5K
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $509.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Seurat Therapeutics do?
- Seurat Therapeutics is a biopharmaceutical company focused on discovering and developing novel neurotherapeutics, with research centered on immune signaling in brain health. Its work addresses conditions such as migraine and other neurological diseases.
- How much funding has Seurat Therapeutics raised?
- Seurat Therapeutics has disclosed $773.5K raised across 1 round.
- Where is Seurat Therapeutics headquartered?
- Seurat Therapeutics is headquartered in Chicago, US.